Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Revenues	$ 222,818	$ 145,639
Cost of revenues	160,964	110,356
Gross profit	61,854	35,283
Operating expenses:
Research and development	11,425	7,991
Selling, general and administrative	43,091	31,600
Amortization of acquisition related intangibles	1,733	2,152
Change in fair value	6,682	4,922
Restructuring	0	(14)
Total operating expenses	62,931	46,651
Operating loss	(1,077)	(11,368)
Interest income, net	3,708	1,302
Other expense, net	(265)	(736)
Income (loss) before income tax (benefit) expense	2,366	(10,802)
Income tax (benefit) expense	(3,667)	309
Net income (loss)	$ 6,033	$ (11,111)
Net income (loss) per common share
Basic (in dollars per share)	$ 0.16	$ (0.37)
Diluted (in dollars per share)	$ 0.16	$ (0.37)
Weighted average number of common shares outstanding
Basic (in shares)	36,990	29,825
Diluted (in shares)	37,718	29,825

The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Name:	us-gaap_AmortizationOfAcquisitionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.